Geode Capital Management’s CASI Pharmaceuticals CASI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $22.2K | Sell |
|
|||||
|
2025
Q1 | $41.8K | Hold |
|
|||||
|
2024
Q4 | $54.8K | Hold |
|
|||||
|
2024
Q3 | $115K | Sell |
|
|||||
|
2024
Q2 | $122K | Hold |
|
|||||
|
2024
Q1 | $80.2K | Hold |
|
|||||
|
2023
Q4 | $162K | Hold |
|
|||||
|
2023
Q3 | $56.9K | Hold |
|
|||||
|
2023
Q2 | $55.3K | Sell |
|
|||||
|
2023
Q1 | $226K | Hold |
|
|||||
|
2022
Q4 | $171K | Sell |
|
|||||
|
2022
Q3 | $255K | Sell |
|
|||||
|
2022
Q2 | $329K | Buy |
|
|||||
|
2022
Q1 | $923K | Hold |
|
|||||
|
2021
Q4 | $912K | Buy |
|
|||||
|
2021
Q3 | $1.12M | Buy |
|
|||||
|
2021
Q2 | $1.09M | Sell |
|
|||||
|
2021
Q1 | $2.62M | Buy |
|
|||||
|
2020
Q4 | $2.82M | Buy |
|
|||||
|
2020
Q3 | $1.21M | Buy |
|
|||||
|
2020
Q2 | $1.95M | Buy |
|
|||||
|
2020
Q1 | $1.44M | Buy |
|
|||||
|
2019
Q4 | $2.1M | Buy |
|
|||||
|
2019
Q3 | $2.26M | Buy |
|
|||||
|
2019
Q2 | $2.12M | Buy |
|
|||||
|
2019
Q1 | $1.79M | Buy |
|
|||||
|
2018
Q4 | $2.35M | Buy |
|
|||||
|
2018
Q3 | $2.38M | Buy |
|
|||||
|
2018
Q2 | $3.88M | Buy |
|
|||||
|
2018
Q1 | $940K | Hold |
|
|||||
|
2017
Q4 | $733K | Buy |
|
|||||
|
2017
Q3 | $67K | Hold |
|
|||||
|
2017
Q2 | $40K | Sell |
|
|||||
|
2017
Q1 | $54K | Hold |
|
|||||
|
2016
Q4 | $44K | Hold |
|
|||||
|
2016
Q3 | $42K | Hold |
|
|||||
|
2016
Q2 | $45K | Hold |
|
|||||
|
2016
Q1 | $41 | Hold |
|
|||||
|
2015
Q4 | $37K | Hold |
|
|||||
|
2015
Q3 | $41K | Hold |
|
|||||
|
2015
Q2 | $69K | Hold |
|
|||||
|
2015
Q1 | $56K | Hold |
|
|||||
|
2014
Q4 | $51K | Hold |
|
|||||
|
2014
Q3 | $69K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $70K | Hold |
|
|||||
|
2013
Q4 | $66K | Sell |
|
|||||
|
2013
Q3 | $69K | Buy |
|
|||||
|
2013
Q2 | $79K | Buy |
|